文献速递肝胆胰外科围术期管理与 ERAS

全胰切除术替代胰十二指肠切除术用于胰腺瘘高危患者的系统评价与荟萃分析

Systematic Review and Meta-analysis of the Role of Total Pancreatectomy as an Alternative to Pancreatoduodenectomy in Patients at High Risk for Postoperative Pancreatic Fistula: Is it a Justifiable Indication?
PubMed 文献 · Ann Surg · 2023-05-09

该系统评价与荟萃分析共纳入5项研究、707例患者(全胰切除术334例,高危胰十二指肠切除术373例),比较两种术式的短期死亡率和主要并发症。结果显示,全胰切除术与胰十二指肠切除术的90天死亡率无差异(6.3% vs. 6.2%;RR=1.04,95%CI 0.56-1.93),主要并发症发生率在全胰切除术中更低(26.7% vs. 38.3%;RR=0.65,95%CI 0.48-0.89),但在匹配或随机化研究中这一差异未达统计学意义(29.0% vs. 36.9%;RR=0.73,95%CI 0.48-1.10)。

要点

  • POPF高危患者中,全胰切除术与PD的90天死亡率无差异(6.3% vs. 6.2%)。
  • 总体主要并发症TP更低,但匹配或随机化研究中差异无统计学意义。
  • 两种术式长期总体健康状况相当(77% vs. 76%;P=0.857)。

核心结论

  • 在POPF高危患者中,全胰切除术相比胰十二指肠切除术未降低短期死亡率与主要并发症。
  • 若全胰切除术作为补救性手术使用,其长期生活质量与PD相当,结果令人安心。

研究设计与样本

  • 系统评价与荟萃分析,检索Pubmed、Embase(Ovid)和Cochrane Library至2022年10月发表的研究。
  • 共纳入5项研究、707例患者(TP 334例,高危PD 373例),包括1项随机对照试验和4项观察性研究。

主要发现

  • TP与PD的90天死亡率无差异(6.3% vs. 6.2%;RR=1.04 [95%CI 0.56-1.93])。
  • TP主要并发症发生率低于PD(26.7% vs. 38.3%;RR=0.65 [95%CI 0.48-0.89])。
  • 匹配或随机化研究中主要并发症差异无统计学意义(29.0% vs. 36.9%;RR=0.73 [95%CI 0.48-1.10])。
  • 两项研究以中位30-52个月随访EORTC QLQ-C30评估生活质量,TP与PD总体健康状况相当(77% [±15] vs. 76% [±20];P=0.857)。

关键数值与推荐

  • 主要终点为短期死亡率;次要终点为短期主要并发症(Clavien-Dindo分级≥IIIa)和生活质量。

临床怎么用

  • POPF高危患者选择TP替代PD时,不应期待短期死亡率或主要并发症的改善。
  • TP作为补救性手术时,长期生活质量与PD相当,可作为支持性信息用于术前沟通。

局限性

  • 纳入研究仅5项、共707例患者,证据量有限。
  • 仅1项随机对照试验,其余为观察性研究,匹配或随机化分析中主要并发症优势未达统计学意义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Examine the potential benefit of total pancreatectomy (TP) as an alternative to pancreatoduodenectomy (PD) in patients at high risk for postoperative pancreatic fistula (POPF). SUMMARY BACKGROUND DATA: TP is mentioned as an alternative to PD in patients at high risk for POPF, but a systematic review is lacking. METHODS: Systematic review and meta-analyses using Pubmed, Embase (Ovid), and Cochrane Library to identify studies published up to October 2022, comparing elective single-stage TP for any indication versus PD in patients at high risk for POPF. The primary endpoint was short-term mortality. Secondary endpoints were major morbidity (i.e., Clavien-Dindo grade ≥IIIa) on the short-term and quality of life. RESULTS: After screening 1212 unique records, five studies with 707 patients (334 TP and 373 high-risk PD) met the eligibility criteria, comprising one randomized controlled trial and four observational studies. The 90-day mortality after TP and PD did not differ (6.3% vs. 6.2%; RR=1.04 [95%CI 0.56-1.93]). Major morbidity rate was lower after TP compared to PD (26.7% vs. 38.3%; RR=0.65 [95%CI 0.48-0.89]), but no significance was seen in matched/randomized studies (29.0% vs. 36.9%; RR = 0.73 [95%CI 0.48-1.10]). Two studies investigated quality of life (EORTC QLQ-C30) at a median of 30-52 months, demonstrating comparable global health status after TP and PD (77% [±15] vs. 76% [±20]; P =0.857). CONCLUSIONS: This systematic review and meta-analysis found no reduction in short-term mortality and major morbidity after TP as compared to PD in patients at high risk for POPF. However, if TP is used as a bail-out procedure, the comparable long-term quality of life is reassuring.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Stoop TF, Bergquist E, Theijse RT, et al. Systematic Review and Meta-analysis of the Role of Total Pancreatectomy as an Alternative to Pancreatoduodenectomy in Patients at High Risk for Postoperative Pancreatic Fistula: Is it a Justifiable Indication? Ann Surg. 2023. PMID: 37161977. doi:10.1097/SLA.0000000000005895

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。